TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32864990

Group type: EXPERIMENTAL
Intervention: MyDiaText™ (TM education and support application)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 166
Study: 33482619

Group type: EXPERIMENTAL
Intervention: Highest total cholesterol (TC) quartile
Number of subjects: 3741

Group type: COMPARATOR
Intervention: Lowest total cholesterol (TC) quartile
Number of subjects: 3741
Study: 32386127

Group type: EXPERIMENTAL
Intervention: HIV-exposed uninfected children (CHEU)
Number of subjects: 1380

Group type: COMPARATOR
Intervention: HIV-unexposed children (CHU)
Number of subjects: 1380
Study: 33952620

Group type: EXPERIMENTAL
Intervention: n-3 (1,800 mg/day fish oil)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (600 mg/day olive oil)
Number of subjects: 43
Study: 32692245

Group type: EXPERIMENTAL
Intervention: Percutaneous spinal nerve posteromedial ramus destruction
Number of subjects: 118

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 118
Study: 35901367

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 854
Study: 35238218

Group type: EXPERIMENTAL
Intervention: Streamlined consent approaches (six different types including one with a video before the appointment)
Number of subjects: 2618

Group type: COMPARATOR
Intervention: Traditional consent approach (one type)
Number of subjects: 2618
Study: 33306977

Group type: EXPERIMENTAL
Intervention: DLwn (deadlifts with straps based on without-straps 1-repetition max)
Number of subjects: 16

Group type: COMPARATOR
Intervention: DLnn (deadlifts without straps)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: DLww (deadlifts with straps based on with-straps 1-repetition max)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: DLwn and DLww (deadlifts with straps)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: DLwn (deadlifts with straps)
Number of subjects: 16
Study: 35363452

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1-g intravenous bolus)
Number of subjects: 9535

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9535
Study: 34782054

Group type: EXPERIMENTAL
Intervention: Metoclopramide and dummy ondansetron
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Ondansetron and dummy metoclopramide
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Metoclopramide and ondansetron
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Double dummy
Number of subjects: 33
Study: 32349005

Group type: EXPERIMENTAL
Intervention: B125S5 (0.125% bupivacaine + 5 μg sufentanil in 15 mL)
Number of subjects: 169
Study: 36264343

Group type: EXPERIMENTAL
Intervention: m-VISTA technique (test group, TG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Coronally advanced flap (CAF) technique (control group, CG)
Number of subjects: 24
Study: 33903052

Group type: EXPERIMENTAL
Intervention: Cold therapy applied to the incision area after abdominal surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no cold therapy)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cold therapy
Number of subjects: 60
Study: 35040866

Group type: EXPERIMENTAL
Intervention: No artificial sweeteners claim
Number of subjects: 2219

Group type: EXPERIMENTAL
Intervention: 100% Vitamin C claim
Number of subjects: 2219

Group type: EXPERIMENTAL
Intervention: 100% All Natural claim
Number of subjects: 2219

Group type: COMPARATOR
Intervention: No claim (control group)
Number of subjects: 2219

Group type: EXPERIMENTAL
Intervention: All claims
Number of subjects: 2219
Study: 34043108

Group type: EXPERIMENTAL
Intervention: Normal saline with heparin (3000 units to 500 ml of normal saline)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Normal saline without heparin
Number of subjects: 147
Study: 33124987

Group type: EXPERIMENTAL
Intervention: Peer-led web-based intervention including four short videos, an interactive scenario game, and a risk assessment tool.
Number of subjects: 578

Group type: COMPARATOR
Intervention: Control group using an existing website promoting physical activities and healthy living.
Number of subjects: 578
Study: 35759564

Group type: EXPERIMENTAL
Intervention: SONYA device stimulation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (false stimulation)
Number of subjects: 32
Study: 32592861

Group type: EXPERIMENTAL
Intervention: bilateral TBS monotherapy
Number of subjects: 53

Group type: COMPARATOR
Intervention: sham stimulation
Number of subjects: 53
Study: 36315941

Group type: EXPERIMENTAL
Intervention: Physical therapy (PT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Arthroscopic partial meniscectomy
Number of subjects: 0
Study: 33451721

Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg/metoclopramide 10 mg
Number of subjects: 563

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 563
Study: 36416036

Group type: EXPERIMENTAL
Intervention: LISA
Number of subjects: 150

Group type: COMPARATOR
Intervention: InSurE
Number of subjects: 150
Study: 33199443

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus panitumumab
Number of subjects: 474

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Addition of anti-EGFR inhibitors to the chemotherapy agent epirubicin
Number of subjects: 474
Study: 33262195

Group type: EXPERIMENTAL
Intervention: Recombinant tissue-type plasminogen activator (rt-PA) (35-80 mg)
Number of subjects: 1473

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1473
Study: 35319274

Group type: EXPERIMENTAL
Intervention: CBD (2.5 mg):THC (0.035 mg/kg) ratio (1:1)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: CBD (2.5 mg):THC (0.035 mg/kg) ratio (2:1)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: CBD (2.5 mg):THC (0.035 mg/kg) ratio (3:1)
Number of subjects: 28
Study: 33440084

Group type: EXPERIMENTAL
Intervention: Inhaled treprostinil (72 µg, four times daily)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Inhaled treprostinil
Number of subjects: 326

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study: 32471480

Group type: EXPERIMENTAL
Intervention: BFR‐RT (Blood Flow Restriction Resistance Training)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 30
Study: 34193105

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coping Cat Cognitive Behavioral Therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Optimization of Stage 1 treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination treatment (optimization of Stage 1 treatment + addition of the other intervention)
Number of subjects: 0
Study: 34618727

Group type: EXPERIMENTAL
Intervention: Presepsin guidance
Number of subjects: 656

Group type: COMPARATOR
Intervention: Control group (international guidelines)
Number of subjects: 656
Study: 33279459

Group type: COMPARATOR
Intervention: Normal Sleep (NS)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Sleep Restriction (SR)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Sleep Deprivation (SD)
Number of subjects: 154
Study: 34312449

Group type: EXPERIMENTAL
Intervention: 4-week complex, supervised rehabilitation protocol
Number of subjects: 51

Group type: COMPARATOR
Intervention: Home exercise program alone
Number of subjects: 51
Study: 32524499

Group type: EXPERIMENTAL
Intervention: PF-06881894 (6 mg single dose)
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: PF-06881894 (multiple 6 mg doses)
Number of subjects: 573

Group type: COMPARATOR
Intervention: pegfilgrastim-US (6 mg single dose)
Number of subjects: 573

Group type: COMPARATOR
Intervention: pegfilgrastim-US (multiple 6 mg doses)
Number of subjects: 573

Group type: COMPARATOR
Intervention: pegfilgrastim-EU (6 mg single dose)
Number of subjects: 573
Study: 35235720

Group type: EXPERIMENTAL
Intervention: Brexpiprazole (2–4 mg/d for short-term studies; 1–4 mg/d for long-term studies)
Number of subjects: 831

Group type: EXPERIMENTAL
Intervention: Brexpiprazole
Number of subjects: 831

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 831
Study: 33653824

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 17160
Study: 32520909

Group type: EXPERIMENTAL
Intervention: Point-of-care (POC) early infant diagnosis (EID)
Number of subjects: 9539

Group type: COMPARATOR
Intervention: Laboratory-based early infant diagnosis (EID)
Number of subjects: 9539
Study: 35969402

Group type: EXPERIMENTAL
Intervention: Casirivimab and Imdevimab 1200 mg IV
Number of subjects: 815

Group type: EXPERIMENTAL
Intervention: Casirivimab and Imdevimab 2400 mg IV
Number of subjects: 815

Group type: EXPERIMENTAL
Intervention: Casirivimab and Imdevimab 600 mg SC
Number of subjects: 815

Group type: EXPERIMENTAL
Intervention: Casirivimab and Imdevimab 1200 mg SC
Number of subjects: 815

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 815
Study: 33985877

Group type: EXPERIMENTAL
Intervention: General dental practitioners' willingness to repair loose retainers
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Experience with orthodontic services
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Awareness of third-order side effects of bonded retainers
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Justification for permanent retention
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Responsibility for long-term supervision of fixed retainers
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Interest in further training on orthodontic retention
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Appreciation for clinical guidelines
Number of subjects: 71
Study: 33333490

Group type: EXPERIMENTAL
Intervention: Kettlebell exercises
Number of subjects: 10
Study: 33166551

Group type: EXPERIMENTAL
Intervention: Hydrus Microstent (Ivantis, Inc) implantation
Number of subjects: 556

Group type: COMPARATOR
Intervention: Cataract surgery alone
Number of subjects: 556
Study: 34873344

Group type: EXPERIMENTAL
Intervention: ITCA 650
Number of subjects: 4156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4156
Study: 33844995

Group type: EXPERIMENTAL
Intervention: Tremelimumab (1 mg/kg bodyweight) and durvalumab (20 mg/kg bodyweight) every 4 weeks for four doses, followed by maintenance intravenous durvalumab at the same dose and schedule for nine doses.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Retreatment with the same doses and schedules for tremelimumab and durvalumab.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TMB higher than the median value of 8.3 mutations per Mb in retreated cohort.
Number of subjects: 40
Study: 33091093

Group type: EXPERIMENTAL
Intervention: Integrated NCD-HTS
Number of subjects: 320
Study: 36038485

Group type: EXPERIMENTAL
Intervention: 5‐µM Ca.I A23187 for 10 min
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 70
Study: 32037549

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 155 U
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 74 U
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo (intramuscular saline)
Number of subjects: 125
Study: 36028326

Group type: EXPERIMENTAL
Intervention: Carotid Artery Stenting (CAS)
Number of subjects: 826

Group type: COMPARATOR
Intervention: Carotid Endarterectomy (CEA)
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Composite outcome of adjudicated stroke or incident symptoms
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Adjudicated stroke events
Number of subjects: 826
Study: 34338742

Group type: EXPERIMENTAL
Intervention: Direct transfer to angiography suite (DTAS)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Conventional workflow
Number of subjects: 174
Study: 32873114

Group type: EXPERIMENTAL
Intervention: Standard PMR group (practiced PMR at home every day for two weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo group (practiced PMR for two weeks with additional daily placebo treatment)
Number of subjects: 100
Study: 34088583

Group type: EXPERIMENTAL
Intervention: Genetically determined higher levels of plasma vitamin C
Number of subjects: 0
Study: 34426142

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 114

Group type: COMPARATOR
Intervention: Stretching (active control)
Number of subjects: 114
Study: 34321049

Group type: EXPERIMENTAL
Intervention: Suture technique for securing tracheal tube (TT)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Wilko tie technique for securing TT
Number of subjects: 17

Group type: COMPARATOR
Intervention: Lark's foot tie technique for securing TT
Number of subjects: 17
Study: 32195715

Group type: EXPERIMENTAL
Intervention: Hand strength-focused exercise program (n = 26) from 2 to 6 weeks after injury
Number of subjects: 52

Group type: COMPARATOR
Intervention: Finger range of motion exercises (Control group, n = 26)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Hand strength-focused exercise program (n = 26)
Number of subjects: 52
Study: 35437025

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 50
Study: 34146354

Group type: EXPERIMENTAL
Intervention: Tutorial pointing to perilesional sun damage as a clue to pAK/BD (group A)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Tutorial not pointing to perilesional sun damage (group B)
Number of subjects: 124
Study: 35360515

Group type: EXPERIMENTAL
Intervention: Task Balance Training Program (TBT program)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study: 32019222

Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14, administered orally, twice daily for 12 weeks
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo, administered orally, twice daily for 12 weeks
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 34648913

Group type: EXPERIMENTAL
Intervention: Reduced RUTF dose (intervention arm)
Number of subjects: 516

Group type: COMPARATOR
Intervention: Standard RUTF dose (control arm)
Number of subjects: 516
Study: 34334434

Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS
Number of subjects: 11
Study: 33455099

Group type: EXPERIMENTAL
Intervention: Antiviral therapy
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 132
Study: 33669930

Group type: EXPERIMENTAL
Intervention: AI-driven automated medical-history-taking systems with AI-driven differential-diagnosis lists
Number of subjects: 22

Group type: COMPARATOR
Intervention: AI-driven automated medical-history-taking systems without AI-driven differential-diagnosis lists
Number of subjects: 22
Study: 33564872

Group type: EXPERIMENTAL
Intervention: Monoglycerides (MAGs)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ethyl Esters (EEs)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Triglycerides (TGs)
Number of subjects: 22

Group type: COMPARATOR
Intervention: All supplements (MAGs, EEs, TGs)
Number of subjects: 22
Study: 35917580

Group type: EXPERIMENTAL
Intervention: R‐Vera 300 mg/day
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: R‐Vera 450 mg/day
Number of subjects: 184

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184
Study: 34217769

Group type: EXPERIMENTAL
Intervention: Intracranial Hemorrhage (ICH) identified in infants
Number of subjects: 883

Group type: EXPERIMENTAL
Intervention: Bilateral Grade 2, Grade 3, or Grade 4 ICH at day 7-9
Number of subjects: 883

Group type: EXPERIMENTAL
Intervention: Bilateral Grade 2, any Grade 3, and any Grade 4 ICH at 7-9 days or 36 weeks
Number of subjects: 883

Group type: EXPERIMENTAL
Intervention: Prenatal steroids (2 or more doses)
Number of subjects: 883

Group type: EXPERIMENTAL
Intervention: Multiple gestation and cesarean delivery
Number of subjects: 883
Study: 32829942

Group type: EXPERIMENTAL
Intervention: Vigorous Plantar Myofascial Mobilization (PMM)
Number of subjects: 42
Study: 34156651

Group type: EXPERIMENTAL
Intervention: CoRE + real tDCS
Number of subjects: 33

Group type: COMPARATOR
Intervention: CoRE + sham tDCS
Number of subjects: 33
Study: 34103316

Group type: EXPERIMENTAL
Intervention: SPAIRE approach
Number of subjects: 228
Study: 36344910

Group type: EXPERIMENTAL
Intervention: TEA/PCIA
Number of subjects: 86

Group type: COMPARATOR
Intervention: TEA
Number of subjects: 86
Study: 32440935

Group type: EXPERIMENTAL
Intervention: Corifollitropin-α late-start (day 4)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard administration (day 2)
Number of subjects: 0
Study: 34350678

Group type: EXPERIMENTAL
Intervention: Robust semiparametric logistic model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classic logistic model
Number of subjects: 0
Study: 34525006

Group type: EXPERIMENTAL
Intervention: Isoniazid preventive therapy (IPT)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Non-IFNγ cytokine responses
Number of subjects: 300

Group type: COMPARATOR
Intervention: QFT-Plus
Number of subjects: 300
Study: 35529264

Group type: EXPERIMENTAL
Intervention: Humanistic care combined with predictive nursing
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine nursing
Number of subjects: 90
Study: 33648489

Group type: EXPERIMENTAL
Intervention: Self-administered tests for chronic PGP assessment
Number of subjects: 289

Group type: COMPARATOR
Intervention: Self-administered tests
Number of subjects: 289

Group type: COMPARATOR
Intervention: Self-administered tests vs. clinical examination tests
Number of subjects: 289
Study: 35485068

Group type: EXPERIMENTAL
Intervention: Mexidol 125 mg twice daily
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Mexidol 125 mg daily + placebo
Number of subjects: 333

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 333
Study: 33856821

Group type: EXPERIMENTAL
Intervention: Nicotine metabolite ratio (NMR) calculated as the ratio of plasma cotinine and trans‐3' hydroxycotinine, log-transformed.
Number of subjects: 244
Study: 35322973

Group type: EXPERIMENTAL
Intervention: High-frequency (10 Hz) repetitive transcranial magnetic stimulation (rTMS), 5 sessions
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 22
Study: 36480390

Group type: EXPERIMENTAL
Intervention: Alcohol PRS in no-pain condition (Black participants)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Chronic pain PRS in no-pain condition (White participants)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Chronic pain PRS in pain condition (White participants)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Alcohol PRS (White participants)
Number of subjects: 209
Study: 33545763

Group type: EXPERIMENTAL
Intervention: 7-day gradual early functional exercise program
Number of subjects: 106

Group type: COMPARATOR
Intervention: Routine functional exercises
Number of subjects: 106
Study: 32468916

Group type: EXPERIMENTAL
Intervention: Sulfonylurea treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sulfonylurea-induced hypoglycemia
Number of subjects: 0
Study: 36353135

Group type: EXPERIMENTAL
Intervention: Cognitive-motor dual-task (CMDT) training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cognitive task (CT) training
Number of subjects: 40
Study: 34019710

Group type: EXPERIMENTAL
Intervention: Cardiovascular fitness
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Gross motor skills
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: White matter microstructure (FA, AD, RD)
Number of subjects: 92
Study: 35241222

Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 1414

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 1414
Study: 34710229

Group type: EXPERIMENTAL
Intervention: Digital infrared thermal imaging (DITI)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 224
Study: 32821038

Group type: EXPERIMENTAL
Intervention: Incisional negative-pressure wound therapy (n=785)
Number of subjects: 1548

Group type: COMPARATOR
Intervention: Standard dressings (n=763)
Number of subjects: 1548
Study: 34503198

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 40
Study: 32919196

Group type: EXPERIMENTAL
Intervention: Composite dimension 'Pain or Discomfort' (P/D) in self-reporting health.
Number of subjects: 2422

Group type: EXPERIMENTAL
Intervention: Composite dimension 'Anxiety or Depression' (A/D) in self-reporting health.
Number of subjects: 2422

Group type: EXPERIMENTAL
Intervention: Valuation of stylised EQ-5D states using Discrete Choice Experiments.
Number of subjects: 2422

Group type: EXPERIMENTAL
Intervention: Composite dimension 'Pain or Discomfort' (P/D) in valuation.
Number of subjects: 2422

Group type: EXPERIMENTAL
Intervention: Composite dimension 'Anxiety or Depression' (A/D) in valuation.
Number of subjects: 2422
Study: 35608027

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (twice a week for 30 minutes for 8 weeks)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 12
Study: 33677183

Group type: EXPERIMENTAL
Intervention: Cariprazine
Number of subjects: 1523

Group type: EXPERIMENTAL
Intervention: MADRS severity thresholds
Number of subjects: 1523

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1523
Study: 32016122

Group type: EXPERIMENTAL
Intervention: Proactive Interdisciplinary Self-Management (PRISMA) program with usual care
Number of subjects: 203

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 203
Study: 36451471

Group type: EXPERIMENTAL
Intervention: rosuvastatin/ezetimibe
Number of subjects: 108

Group type: COMPARATOR
Intervention: rosuvastatin
Number of subjects: 108
Study: 35570662

Group type: EXPERIMENTAL
Intervention: Impending pain condition
Number of subjects: 122

Group type: COMPARATOR
Intervention: Impending touch condition
Number of subjects: 122
Study: 34285247

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 101

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 101
Study: 32291702

Group type: EXPERIMENTAL
Intervention: Enhanced Recovery After Surgery (ERAS)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard Recovery Pathway
Number of subjects: 112
Study: 32185995

Group type: EXPERIMENTAL
Intervention: Danggui Sini plus Wuzhuyu Shengjiang Tang (DSWST)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Water
Number of subjects: 25